Cost of antipsychotic polypharmacy in the treatment of schizophrenia. - Wikidata - awgldk - TriplyDB

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

http://www.wikidata.org/entity/Q33327172

about

A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada.Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior Polypharmacy with antipsychotic drugs in patients with schizophrenia: trends in multiple health care systems.Validation of a claims-based antipsychotic polypharmacy measure Reducing psychotropic pharmacotherapy in patients with severe mental illness: a cluster-randomized controlled intervention study.Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice Polypharmacy in the management of patients with schizophrenia on risperidone in a tertiary-care hospital in Malaysia Cost prediction of antipsychotic medication of psychiatric disorder using artificial neural network model.Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria.Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis Is rational antipsychotic polytherapy feasible? A selective review.Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness.Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan.Antipsychotic Use Pattern in People with Psychotic Disorder Living in Board and Care Facilities.Reducing antipsychotic polypharmacy among psychogeriatric and adult patients with chronic schizophrenia.Association of antipsychotic polypharmacy with health service cost: a register-based cost analysis.Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.Improving psychotherapeutic medication prescribing in Florida: implementation of the Florida Medicaid Drug Therapy Management Program (MDTMP).

P2860

Q30485065-13578166-E7A8-4AE9-A2C6-7C5FF685151C Q34746791-08C979B0-C406-46AA-8E67-A7D4ECECE495 Q35175610-C3F2470F-BA93-445E-8D5B-C70A4E3FFCBC Q35608522-98776FAB-E23F-4A04-9928-96A5F0E1BBEB Q35801221-575AFC68-FB1E-4E0C-8585-47CFDB0470A8 Q35906535-69156C63-436F-48EF-A26B-34E5423E5502 Q36065092-85DD8BC3-1A9D-4B78-96B1-4A8FB7469D38 Q37029622-5FE4A718-5098-4C3D-8FAF-B57B8056F7FB Q37294192-F1A7CBD5-3A6E-47AE-9258-DB4D314F6B93 Q37413743-4AF95E38-963F-4862-A86E-529B3FA083EB Q37582708-257D0BCD-0B1B-49F9-A3CC-9AF2848ED6E9 Q37609168-986D5A43-5728-4D5B-A88F-0C7CC51B2957 Q37993473-BE1E2B53-EA22-4407-889C-A5B9002EF41F Q38081872-414AD7EA-0E44-4431-897B-09D5C4124775 Q38769838-F6862ED6-8628-40FD-AB4C-18A037C117DF Q41064310-034C5BA4-2161-4233-9145-8EF7E674AF83 Q42180852-A8DC54B1-322E-4E27-94F8-EBE89ABBD758 Q42835527-64D1D256-3659-407C-B1E4-88A82697DDBB Q43679387-E5D3F4DA-6499-4416-8B7F-FFBB71178394 Q48321579-E5663D3A-2400-4A0C-A1CB-79DD2C3A134C Q48484923-D1F34F28-19E4-4411-8CA5-F7DC5154485F Q50142339-EEFB3791-1BDD-4FFC-BE0D-16905BD04996

P2860

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

http://www.wikidata.org/entity/Q33327172

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@ast

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@en

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@nl

type

label

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@ast

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@en

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@nl

prefLabel

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@ast

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@en

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@nl

P1433

Q33327172-242749FC-62F1-4574-8901-90D3ECDEE2C1

P1476

Q33327172-6F15CB25-1DFF-4C58-8793-D95F036441E4

P2093

Q33327172-935CE851-2D16-4E3E-BAC7-119E263C68FA

Q33327172-9B2F8EB7-B4E3-4086-ACC1-77CE5211158D

Q33327172-F6A9163E-9B4B-44AE-B6A4-01FAA18D4828

P2860

Q33327172-0061695A-CE31-4645-B7B0-8DB659E08EEE

Q33327172-0677A2CB-68EE-4C5B-AA20-6066113066D5

Q33327172-1B88D46E-093C-4B17-ACF8-CD34F5851EF4

Q33327172-39837FCE-4C8D-4980-A82F-B3687A6C91D0

Q33327172-40FA19FA-3909-4F69-B79C-87CF6F1B96E9

Q33327172-479D30FF-A25C-492C-9CD4-C4D70BE4362D

Q33327172-595542F2-400F-4105-9352-1FAB3E7D4A74

Q33327172-5A6A8177-9658-4EDC-980C-38BE656CA16E

Q33327172-67130F3D-9FE1-4D2A-B11A-0172BC78C425

Q33327172-6806E056-3D78-4E9F-B304-321DF290B409

P2888

Q33327172-F49071E3-AB65-475F-8A12-F9B5F8656178

P304

Q33327172-27B686F8-52D0-42C0-BC79-F2CF5F0A3238

P31

Q33327172-35B8F3B8-E685-4620-BC1A-EAFCCD37C791

P356

Q33327172-084BAE5B-E70B-41FA-8995-37E232DA16E9

P478

Q33327172-6738B3D4-E74E-48B6-B6D2-0C21A6A99B98

P50

Q33327172-255D814B-7F35-4C02-B6D3-B9ABCA2E77E6

Q33327172-E6895724-19AD-4764-8FE5-955084E58FA5

P577

Q33327172-84F7DDAE-0EDB-4A7B-A859-2C2A86DEDBAF

P6179

Q33327172-F4AD0C0A-76A1-4C14-B7F5-8FD71A86969D

P698

Q33327172-BB7AF0F5-B56F-40BE-B99E-EA8ACB0A9E2F

P921

Q33327172-918E1AD0-890C-4A77-A125-465154E52B8E

P932

Q33327172-7B52F3DD-669D-4BC4-B2B8-05E42BA1CF4B

P356

P1433

P1476

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

@en

P2093

Baojin Zhu

http://www.w3.org/2001/XMLSchema#string

Christoph U Correll

http://www.w3.org/2001/XMLSchema#string

Douglas E Faries

http://www.w3.org/2001/XMLSchema#string

P2860

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics.

Practice guideline for the treatment of patients with schizophrenia, second edition.

Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations.

Antipsychotic medication coprescribing in a large state hospital system.

Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies.

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia.

A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

P2888

P304

19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-244X-8-19

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Haya Ascher-Svanum

P577

2008-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044296373

http://www.w3.org/2001/XMLSchema#string

P698

18394168

http://www.w3.org/2001/XMLSchema#string

P921

P932

2364616

http://www.w3.org/2001/XMLSchema#string